# Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT)

> **NCT00680433** · PHASE4 · COMPLETED · sponsor: **Northside Clinic, Australia** · enrollment: 83 (actual)

## Conditions studied

- Major Depressive Episode

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00680433
- **Lead sponsor:** Northside Clinic, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2013-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00680433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00680433, "Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00680433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*